Mass Healing is one of the only local organizations actively drafting, filing and consulting on statewide psychedelics legislation in collaboration with community members, lawmakers, researchers and clinicians.
Policy Overview
While most psychedelics remain classified as Schedule 1 Controlled Substances by the DEA, this legal landscape is shifting rapidly with recognition of the potential therapeutic benefits of psychedelic medicine to treat serious mental illness and substance abuse disorders. On a federal level, this is most evident in the President’s April 2026 Executive Order (14401), which called for the FDA to fast-track regulatory review of psychedelic compounds with promising results in clinical trials. While the regulatory landscape of psychedelics remains complex and dynamic, Mass Healing is focused on resource and coalition building in anticipation of wider psychedelic medicine adoption in Massachusetts.
Mass Healing brings evidence, education, and community to the center of the psychedelic conversation in Massachusetts. Our credibility shows in the results: when the House passed a psychedelic treatment pilot this July, it was built on bills our research and testimony helped shape.
Mass Healing has coordinated written, verbal and in-person testimony for State House hearings including perspectives from first-responders, veterans and leading academic researchers at MGH’s Center for the Neuroscience of Psychedelics.
We are committed to inclusive principles and incorporating diverse voices from communities across the state. We partner with local and national organizations to host events, offer education to the community and provide emerging best practices for providers interested in supporting psychedelic therapies.
Current Legislation
On July 8, 2026, the Massachusetts House voted 148–2 to pass economic development legislation that includes a five-year psychedelic treatment pilot program — adopted by unanimous amendment. The pilot draws on bills Mass Healing helped develop and coordinate testimony for, including H.4200 (Rep. O'Day) and S.1400 (Sen. Friedman).
The program would authorize up to three licensed mental health clinics to provide supervised, on-site treatment using naturally occurring psychedelics, under Department of Public Health oversight, with required tracking of patient outcomes for depression, anxiety, PTSD, and substance use disorder. It also directs the state to facilitate federally authorized research on psilocybin, ibogaine, 5-MeO-DMT, and MDMA.
Where it stands
Passed the House July 8; awaiting action in the Senate. If both chambers pass differing versions, the final language will be settled in a conference committee before heading to Governor Healey. Last updated July 25, 2026.
Bills We’ve Been Involved In
HD.1003, Sponsor: Rep Kearney
A proposal for a comprehensive psilocybin legalization program, allowing trained and licensed professionals to administer psilocybin-assisted therapy to qualified patients. It creates a state-run licensing system for cultivators, certifies support service providers, and establishes an independent advisory board to oversee the program.
HD.4107, Sponsor: Rep Sabadosa
The establishment of a 5-site pilot program to create nonprofit therapeutic centers offering psilocybin treatment to address qualifying mental health needs. The program would create licensure requirements and training standards for medical professionals, psychiatrists, psychologists, and therapists seeking to obtain a psilocybin facilitator license. The Department of Public Health (DPH) will oversee the program with input from a diverse advisory board of experts and experienced practitioners.
HD.3368, Sponsor: Rep Owens
Removal of criminal penalties for the possession, ingestion, growing, and non-commercial transport, and transfer of psilocybin and psilocin for individuals aged 21+ who are veterans, current or former law enforcement officers, or those with qualifying medical conditions.
Additional psychedelic policy bills
| # | Bill | Docket | Sponsor | One-line summary |
|---|---|---|---|---|
| 1 | S.1400 | SD.1624 | Sen. Friedman | Pilot allowing monitored psychedelic mental health care for clinically appropriate patients in licensed treatment facilities |
| 2 | H.2203 | HD.4196 | Rep. Decker | DPH pilot for psilocybin services for PTSD, end-of-life distress, depression |
| 3 | H.2532 | HD.4017 | Rep. Sabadosa | Five-site pilot of nonprofit therapeutic psilocybin centers across five regions |
| 4 | H.2506 | HD.3368 | Rep. Owens | Decriminalizes psilocybin/psilocin possession, growing, and non-commercial transfer for veterans, law enforcement, and qualifying patients 21+ |
| 5 | H.4050 | HD.1003 | Rep. Kearney | Comprehensive adult-use psilocybin framework: licensing, support services, cultivation, taxation |
| 6 | S.1538 | SD.323 | Sen. Fernandes | EOHHS program promoting breakthrough treatments for veterans and first responders |
| 7 | H.1624 | HD.4243 | Rep. Connolly | Task force on equitable access to psilocybin and entheogenic plants |
| 8 | H.2225 | HD.3020 | Reps. Montaño & Connolly | Broad harm-reduction/racial-justice bill deregulating possession of certain controlled substances |
| 9 | H.1858 | HD.188 | Rep. Lombardo (by request of Timothy Morris) | Removes criminal penalties for limited psilocybin possession |
| 10 | S.1113 | SD.870 | Sen. Friedman (by request of Timothy Morris) | Senate companion: removes criminal penalties for limited psilocybin possession |
| 11 | H.1726 | HD.3895 | Rep. Gómez (by request of Henry Morgan) | Modifies criminal disposition of limited psilocybin possession offenses |
Get involved.
If you feel called to support policies that expand access to psychedelic medicine and mental health care, we’d love to hear from you.